Methods: A group of symptomatic female TMD patients was compared to an age and sex matched group of individuals with no TMD symptoms in a group of Turkish women.
Results: There is a higher prevalance of use of postmenopausal hormones among females with TMD compared to age and sex matced group without TMD.
Conclusion: Clinicians need to concerned that patients taking replacement estrogens are at increased risk of developing TMDs.